Researcher
Tom Venken
- Disciplines:Biochemistry and metabolism, Systems biology, Medical biochemistry and metabolism
Affiliations
- Biochemistry, Molecular and Structural Biology (Division)
Member
From12 Oct 2009 → 31 Dec 2017
Publications
1 - 10 of 23
- PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial(2023)
Authors: Liselore Loverix, Ignace Vergote, Pieter Busschaert, Tom Venken, Bram Boeckx, Hilde Brems, Els Van Nieuwenhuysen, Thaïs Baert, Sileny Han, Patrick Neven, et al.
Pages: 131 - 139 - Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer(2023)
Authors: Elien Heylen, Paulien Verstraete, Linde Van Aerschot, Tom Venken, David Nittner, Anne Uyttebroeck, Heidi Segers, Diether Lambrechts, Jan Cools, Kim De Keersmaecker, et al.
Pages: 1862 - 1878 - Multiomics and spatial mapping characterizes human CD8+T cell states in cancer(2023)
Authors: Stefan Naulaerts, Daniel Borras Morales, Julie Messiaen, Isaure Vanmeerbeek, Jenny Sprooten, Dena Panovska, Yannick Van Herck, Lendert Gelens, Tom Venken, Oliver Bechter, et al.
- Analysis of cell free DNA to predict outcome to Bevacizumab combination therapy in metastatic colorectal cancer patients(2023)
Authors: Tom Venken, Ingrid Arijs, Diether Lambrechts
- Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer(2022)
Authors: Pieter Busschaert, Siel Olbrecht, An Coosemans, Wouter Froyman, Liselore Loverix, Els Van Nieuwenhuysen, Sileny Han, Toon Van Gorp, Tom Venken, Ruben Heremans, et al.
- DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer(2020)
Authors: Eva Galle, Bernard Thienpont, Sarah Cappuyns, Tom Venken, Pieter Busschaert, Matthias Van Haele, Tania Roskams, Jos van Pelt, Chris Verslype, Jeroen Dekervel, et al.
- Enhancing the Performance of DNA Surface-Hybridization Biosensors through Target Depletion(2019)
Authors: Stefanos Nomidis, Tom Venken, Enrico Carlon
Pages: 12276 - 12283 - Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization(2019)
Authors: Tom Venken
- D-Peptides as inhibitors of PR3-membrane interactions(2018)
Authors: Ksenia Maximova, Tom Venken, Nathalie Reuter, Joanna Trylska
Pages: 458 - 466 - Computational Studies of the Active and Inactive Regulatory Domains of Response Regulator PhoP Using Molecular Dynamics Simulations(2017)
Authors: Xiaoyu Qing, Hans Steenackers, Tom Venken, Marc De Maeyer, Arnout Voet
Patents
1 - 2 of 2
- Disease detection in liquid biopsies (Inventor)
- Disease detection in liquid biopsies (Inventor)